POU Domain Factor Brn-3b is Essential for Retinal Ganglion Cell Differentiation and Survival but Not for Initial Cell Fate Specification
Overview
Reproductive Medicine
Affiliations
While the mammalian retina is well understood at the anatomical and physiological levels, little is known about the mechanisms that give rise to the retina's highly ordered pattern or its diverse neuronal cell types. Previous investigations have shown that gene disruption of the POU-IV class transcription factor Brn-3b (Brn-3.2) resulted in the loss of most retinal ganglion cells in retinas of postnatal mice. Here, we used lacZ and human placental alkaline phosphatase genes knocked into the brn-3b locus to follow the fate of brn-3b-mutant cells in the developing retina. We found that Brn-3b was not required for the initial commitment of retinal ganglion cell fate or for the migration of ganglion cells to the ganglion cell layer. However, Brn-3b was essential for the normal differentiation of retinal ganglion cells; without it, the cells underwent enhanced apoptosis. Retinal ganglion cells lacking brn-3b extended processes at the appropriate time in development, but these processes were disorganized, resulting in a thinner optic nerve. Explanted retinas from brn-3b-null embryos also extended processes when cultured in vitro, but the processes were shorter and less bundled than in wild-type retinas. Ultrastructural and marker analyses showed that the processes of mutant ganglion cells had dendritic rather than axonal features, suggesting that mutant cells formed dendrites in place of axons. These results suggest that Brn-3b regulates the activity of genes whose products play essential roles in the formation of retinal ganglion cell axons.
Pascalau R, Badea T Front Ophthalmol (Lausanne). 2024; 3:1180142.
PMID: 38983012 PMC: 11182120. DOI: 10.3389/fopht.2023.1180142.
Xu M, Li S, Xie X, Guo L, Yu D, Zhuo J J Neurosci. 2024; 44(8).
PMID: 38267260 PMC: 10883659. DOI: 10.1523/JNEUROSCI.1718-23.2024.
Lee H, Weinberg-Wolf H, Lee H, Lee T, Conte J, Godoy-Parejo C PLoS Biol. 2023; 21(11):e3002386.
PMID: 37983249 PMC: 10695396. DOI: 10.1371/journal.pbio.3002386.
Soucy J, Aguzzi E, Cho J, Gilhooley M, Keuthan C, Luo Z Mol Neurodegener. 2023; 18(1):64.
PMID: 37735444 PMC: 10514988. DOI: 10.1186/s13024-023-00655-y.
Biswas S, Chan C, Rubenstein J, Gan L Dev Biol. 2023; 503:10-24.
PMID: 37532091 PMC: 10658356. DOI: 10.1016/j.ydbio.2023.07.007.